A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer

CompletedOBSERVATIONAL
Enrollment

155

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

October 31, 2021

Conditions
Esophageal Cancer
Trial Locations (2)

510080

Guangdong Provincial People's Hospital, Guangzhou

515031

Shantou Central Hospital, Shantou

All Listed Sponsors
collaborator

The People's Hospital of Gaozhou

OTHER

collaborator

The General Hospital of Southern Theater Command

OTHER

collaborator

Affiliated Cancer Hospital & Institute of Guangzhou Medical University

OTHER

collaborator

First Affiliated Hospital of Shantou University Medical College

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Shantou Central Hospital

OTHER

collaborator

Shenzhen People's Hospital

OTHER

lead

Guangdong Provincial People's Hospital

OTHER

NCT04822103 - A Real-World Study of Immune Checkpoint Inhibitors and Chemotherapy for Advanced Esophageal Cancer | Biotech Hunter | Biotech Hunter